GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Guizhou Sanli Pharmaceutical Co Ltd (SHSE:603439) » Definitions » Dividend Payout Ratio

Guizhounli Pharmaceutical Co (SHSE:603439) Dividend Payout Ratio : 0.00 (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Guizhounli Pharmaceutical Co Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Guizhounli Pharmaceutical Co's Dividend Payout Ratio for the months ended in Sep. 2024 was 0.00.

The historical rank and industry rank for Guizhounli Pharmaceutical Co's Dividend Payout Ratio or its related term are showing as below:

SHSE:603439' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.17   Med: 0.46   Max: 0.76
Current: 0.25


During the past 11 years, the highest Dividend Payout Ratio of Guizhounli Pharmaceutical Co was 0.76. The lowest was 0.17. And the median was 0.46.

SHSE:603439's Dividend Payout Ratio is ranked better than
75.71% of 140 companies
in the Biotechnology industry
Industry Median: 0.48 vs SHSE:603439: 0.25

As of today (2024-12-11), the Dividend Yield % of Guizhounli Pharmaceutical Co is 1.42%.

During the past 11 years, the highest Trailing Annual Dividend Yield of Guizhounli Pharmaceutical Co was 2.09%. The lowest was 0.51%. And the median was 1.49%.

Guizhounli Pharmaceutical Co's Dividends per Share for the months ended in Sep. 2024 was ¥0.00.

During the past 12 months, Guizhounli Pharmaceutical Co's average Dividends Per Share Growth Rate was 100.00% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Guizhounli Pharmaceutical Co Dividend Payout Ratio Historical Data

The historical data trend for Guizhounli Pharmaceutical Co's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guizhounli Pharmaceutical Co Dividend Payout Ratio Chart

Guizhounli Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 0.76 - 0.17

Guizhounli Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 1.27 -

Competitive Comparison of Guizhounli Pharmaceutical Co's Dividend Payout Ratio

For the Biotechnology subindustry, Guizhounli Pharmaceutical Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guizhounli Pharmaceutical Co's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Guizhounli Pharmaceutical Co's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Guizhounli Pharmaceutical Co's Dividend Payout Ratio falls into.



Guizhounli Pharmaceutical Co Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Guizhounli Pharmaceutical Co's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2023 )/ EPS without NRI (A: Dec. 2023 )
=0.1/ 0.6
=0.17

Guizhounli Pharmaceutical Co's Dividend Payout Ratio for the quarter that ended in Sep. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Sep. 2024 )/ EPS without NRI (Q: Sep. 2024 )
=0/ 0.182
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Guizhounli Pharmaceutical Co (SHSE:603439) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Guizhounli Pharmaceutical Co Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Guizhounli Pharmaceutical Co's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Guizhounli Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Xiayun Industrial Park, Pingba District, Guizhou Province, Anshun, CHN, 561000
Guizhou Sanli Pharmaceutical Co Ltd is engaged in Chinese pharmaceutical research, development, production and marketing. The company produces and sells soft capsules, hard capsules, sprays (including Chinese medicine extraction) and provides Chinese medicine science and technology consulting services. Its products include Pediatric medication; Respiratory system medication; Cardiovascular and cerebrovascular drugs; Digestive medicine; Trauma injury medication; Rehabilitation medicine; and Ophthalmic medicine.
Executives
Zhang Hai Director
Wang Jue Ben senior management
Zhang Hong Yu Directors, senior managers
Wang Yi senior management
Zhang Qian Fan Directors, senior managers
Sheng Yong Jian Director

Guizhounli Pharmaceutical Co Headlines

No Headlines